Clinical Trial Update: PACMAN - PAcing for CardioMyopathies, a EuropeAN Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for PACMAN evaluating pacing therapy for cardiomyopathy in heart failure; the study sponsored by Boston Scientific has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Pacemaker system (pacemaker)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure | Phase 4 | Status: COMPLETED